Close Menu

NEW YORK (360Dx) – Genetic Signatures today said that it has received regulatory approvals in Australia and Europe for separate enteric products.

Australia's Therapeutic Goods Administration has approved the firm's Enteric Viral Detection product. Additionally, its EasyScreen Enteric Pathogen Detection Kit range received CE-IVD marking.

The company had previously secured regulatory approval for its Enteric Protozoan, Enteric Bacterial, and C. difficile detection products, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.